A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
University of Rochester
University of Rochester
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
City of Hope Medical Center